| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 203,2 k € | -7.1% | 218,7 k € | -6.2% | 233,2 k € | +40.6% | 165,9 k € | -14.5% | 194,0 k € | -19.4% | 240,7 k € | +5.4% | 228,3 k € | +33.0% | 171,7 k € | -4.5% | 179,9 k € | -29.1% | 253,8 k € | +23.5% | 205,5 k € | -0.2% | 205,8 k € | +8.4% | 189,9 k € | +18.8% | 159,8 k € | +44.3% | 110,8 k € | +2.4% | 108,2 k € | +59.3% | 67,9 k € | |
| EBITDA | 88,7 k € | -17.6% | 107,6 k € | -13.2% | 124,0 k € | +76.9% | 70,1 k € | -40.8% | 118,5 k € | +12.1% | 105,7 k € | +3.4% | 102,3 k € | +56.0% | 65,5 k € | -13.9% | 76,1 k € | -51.8% | 157,8 k € | +36.0% | 116,0 k € | +35.3% | 85,8 k € | -14.9% | 100,7 k € | +14.4% | 88,1 k € | +1.6% | 86,7 k € | +4.6% | 82,9 k € | +63.5% | 50,7 k € | |
| Operating profit | 28,7 k € | -37.6% | 46,0 k € | -27.3% | 63,3 k € | +554.4% | 9,7 k € | -81.0% | 50,9 k € | +41.8% | 35,9 k € | +43.3% | 25,1 k € | +154.6% | -45,9 k € | -28.4% | -35,8 k € | -183.8% | 42,7 k € | -18.0% | 52,1 k € | +354.5% | 11,5 k € | -62.0% | 30,1 k € | +49.7% | 20,1 k € | -63.7% | 55,4 k € | +7.4% | 51,6 k € | +88.4% | 27,4 k € | |
| Profit/loss | 24,4 k € | -36.6% | 38,4 k € | -40.8% | 64,9 k € | +266.4% | 17,7 k € | -62.7% | 47,5 k € | -5.3% | 50,1 k € | +51.6% | 33,1 k € | +160.6% | -54,6 k € | +6.8% | -58,6 k € | -344.2% | 24,0 k € | +3882.9% | 602,4 € | +107.7% | -7,8 k € | -185.2% | 9,2 k € | +336.3% | 2,1 k € | -94.3% | 37,0 k € | +14.6% | 32,3 k € | +54.4% | 20,9 k € | |
| Equity | 155,9 k € | +0.2% | 155,6 k € | +5.7% | 147,1 k € | +24.4% | 118,3 k € | -15.3% | 139,6 k € | +51.6% | 92,0 k € | +119.7% | 41,9 k € | +122.8% | 18,8 k € | -74.4% | 73,4 k € | -44.4% | 132,0 k € | +22.2% | 108,0 k € | +0.6% | 107,4 k € | -6.8% | 115,2 k € | +8.6% | 106,0 k € | +2.0% | 103,9 k € | +55.4% | 66,9 k € | +93.6% | 34,5 k € | |
| Total assets | 550,9 k € | -14.0% | 640,7 k € | +0.7% | 636,1 k € | -12.3% | 725,2 k € | +3.7% | 699,3 k € | -6.9% | 751,4 k € | -7.9% | 815,6 k € | -21.1% | 1,0 M € | +11.6% | 926,7 k € | -33.6% | 1,4 M € | +16.8% | 1,2 M € | +61.9% | 738,1 k € | -1.7% | 750,9 k € | -5.2% | 792,1 k € | +91.2% | 414,3 k € | +4.1% | 398,1 k € | -9.6% | 440,2 k € | |
| Cash | 163,6 k € | +9.8% | 148,9 k € | +41.6% | 105,2 k € | +22.5% | 85,9 k € | +7.6% | 79,8 k € | +79.5% | 44,5 k € | -49.5% | 88,0 k € | -61.8% | 230,4 k € | +1351.3% | 15,9 k € | -93.5% | 245,9 k € | -52.6% | 519,1 k € | +458.7% | 92,9 k € | +21.3% | 76,6 k € | +15.5% | 66,3 k € | -32.8% | 98,7 k € | +72.1% | 57,4 k € | -12.1% | 65,2 k € | |
| Debts | 386,9 k € | -19.0% | 477,4 k € | -0.8% | 481,4 k € | -19.7% | 599,5 k € | +7.6% | 557,1 k € | -15.0% | 655,8 k € | -14.9% | 771,0 k € | -21.8% | 986,0 k € | +16.3% | 848,0 k € | -32.6% | 1,3 M € | +17.1% | 1,1 M € | +72.8% | 622,4 k € | -1.8% | 634,1 k € | -7.5% | 685,8 k € | +123.1% | 307,4 k € | -6.0% | 326,8 k € | -19.0% | 403,3 k € | |
| Staff | 1,3 | 2 | 2 | 2 | 1,8 | 2,2 | 2,3 | — | 2 | 2 | 1,9 | 2,5 | 1,5 | 1,5 | 0,5 | 0,5 | 0,4 | |||||||||||||||||
Private limited company · Oudenaarde · incorporated on 28/03/2008 · 1,3 ETP
Private limited company profitable and well capitalised. Cash position rising (+9.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
VERZELE PHARMA is a Private limited company incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oudenaarde. It employs on average 1,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette